1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Market Access Impact: Asthma/COPD (EU5)

  • October 2015
  • Firstword Pharma
Report ID: 3362820

Summary

Table of Contents




Are prescribing constraints costing your brand market share?


Doctors can’t always prescribe the asthma/COPD drugs they want to prescribe. The reason: market barriers—things like pricing, reimbursement, guidelines, patient preferences, and more.


Barriers like these are a threat to leading brands’ market share. But they also offer opportunities for brands to take market share from competitors.


FirstView’s Market Access Impact in Asthma/COPD report takes an in-depth look at the way barriers affect asthma/COPD prescribing, and reveals which brands are winning and losing market share because of it. See what brands are included in this report


Not your market? Click here to see the US Edition







Answering key questions

Packed with physician insight into seven of the leading asthma/COPD brands, Market Access Impact in Asthma/COPD answers key questions like:

Seretide: a top brand in the US, where does Seretide rank in the EU5 market?
Eklira: would eliminating market barriers move Eklira ahead of competing brands?
Foradil: is reimbursement or patient preference the key to Foradil’s market share gains?
Onbrez: which is the bigger problem for Onbrez: guidelines, or formulary availability?
Serevent: which competing brands does Serevent take the most market share from?
Spiriva: with nearly equal barrier-related gains and losses, what can Spiriva do to tip the scales in its favour?
Symbicort: where does over half of Symbicort’s lost share go? (the answer may surprise you)



Key Issues Explored

Market Access Impact in Asthma/COPD explores key issues affecting asthma/COPD drug makers. You’ll learn:

How barriers affect market access:

What brands do doctors prescribe the most?
How many prescriptions do barriers affect?
Which barriers have the biggest effect?

How barriers affect your brand:

How many doctors prescribe your brand? How many don’t, but would consider it?
Why don’t doctors prescribe your brand? What do they prescribe instead?
Which competing brands does your brand take market share from?


A Report Based on Expert Knowledge

Market Access Impact in Asthma/COPD is based on a survey of 150 EU5 physicians—78 pulmonologists and 72 general practitioners.

All respondents have:

Been practicing for 2+ years
Prescribed at least one of the listed products
Seen at least 50 patients with asthma or COPD in total in the last month

Get Answers On The Following Brands

Seretide (fluticasone/salmeterol; GlaxoSmithKline)
Eklira (aclidinium; AstraZeneca)
Foradil (formoterol Novartis/Merck & Co.)
Onbrez (indacaterol; Novartis)
Serevent (salmeterol; GlaxoSmithKline)
Spiriva (tiotropium; Boehringer Ingelheim)
Symbicort (budesonide/formoterol; AstraZeneca)

Add the US report to your order and get a free comparison report
Also available, the Market Access Impact in Asthma/COPD—US edition.

Based on a survey of 100 physicians from the United States, the report reveals how market barriers affect the leading asthma/COPD brands in the US market.

Order the EU5 and US reports together and you’ll receive a free companion report comparing results from both markets.

Email us for details or call +1 212-220-0880 or +44(0)20.7665.9240

MONEY BACK GUARANTEE!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.


About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.
Learn more at www.firstwordgroup.com.




Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...

Tumor Markers Testing Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities

  • $ 52400
  • Industry report
  • June 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.